Clinical Trial Update: Study of the Efficacy of Sulforaphane in Children Aged 6 to 12 With Attention Deficit Disorder With or Without Hyperactivity [NA]

View source ↗

Summary

A clinical trial evaluating sulforaphane for attention deficit hyperactivity disorder in children aged 6 to 12; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Attention Deficit Disorder | NA | Status: NOT_YET_RECRUITING